Finoriq research workspace
Adagio Medical Holdings, Inc. (ADGM) SEC Filings & Filing Highlights
Adagio Medical Holdings, Inc. offers treatment for cardiac arrhythmias, including atrial. Review ADGM SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
- Company
- Adagio Medical Holdings, Inc. (ADGM)
- Ticker
- ADGM
- Market Cap
- $12M
- Latest Price
- $0.5396
- Industry
- Medical Devices
Adagio Medical Holdings, Inc. (ADGM) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Adagio Medical Holdings, Inc. (ADGM).
| Event | Form | Date |
|---|---|---|
| Broker Non-VotesOn June 16, 2026, Adagio Medical Holdings, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The st... | 8-K5.07 | 2026-06-16 |
| Dated: June 12, 2026On June 12, 2026, Adagio Medical Holdings, Inc. (the “Company”) received a notice from the Listing Qualifications Department of The Nasdaq... | 8-K3.01 | 2026-06-12 |
| Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation Sy...Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachyc... | 8-K8.01 | 2026-05-21 |
| Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical ProgressAdagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress | 8-K2.02 | 2026-05-12 |
| Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation SystemAdagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System | 8-K8.01 | 2026-04-27 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.